26 authors.
Laura CampisiDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. laura.campisi@mssm.edu.ORCID 0000-0003-4173-4521 Jessica S Y HoDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0003-2234-2602 Anastasia GromovaDepartment of Pathology and Laboratory Medicine, University of California, Irvine, Irvine, CA, USA.
Frederick J ArnoldDepartment of Pathology and Laboratory Medicine, University of California, Irvine, Irvine, CA, USA.ORCID 0000-0003-1927-264X Lorena MoscaMedical Genetics Unit, Department of Laboratory Medicine, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Xueyan MeiBioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Yesai FstkchyanDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Denis TorreDepartment of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Cindy BeharryDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Marta Garcia-FornSeaver Autism Center for Research and Treatment, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Miguel Jiménez-AlcázarSeve Ballesteros Foundation Brain Tumor Group, Molecular Oncology Program, Spanish National Cancer Research Centre, Madrid, Spain.
Jack PrazichDepartment of Bioengineering, University of Pennsylvania, Philadelphia, PA, USA.
Zahi A FayadBioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0002-3439-7347 Marcus M SeldinDepartment of Biological Chemistry, Center for Epigenetics and Metabolism, University of California, Irvine, Irvine, CA, USA.
Silvia De RubeisSeaver Autism Center for Research and Treatment, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0001-9383-6883 Craig L BennettDepartment of Pathology and Laboratory Medicine, University of California, Irvine, Irvine, CA, USA.
Lyle W OstrowNeuromuscular Division of the Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0001-7158-5243 Christian LunettaNEMO Clinical Center, Fondazione Serena Onlus, Milan, Italy.
Massimo SquatritoSeve Ballesteros Foundation Brain Tumor Group, Molecular Oncology Program, Spanish National Cancer Research Centre, Madrid, Spain.
Minji ByunDepartment of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Neil A ShneiderDepartment of Neurology, Center for Motor Neuron Biology and Disease, Columbia University, New York, NY, USA.
Albert R La SpadaDepartment of Pathology and Laboratory Medicine, University of California, Irvine, Irvine, CA, USA. alaspada@hs.uci.edu.
Ivan MarazziDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. ivan.marazzi@mssm.edu.ORCID 0000-0003-3376-0922 La Spada Outstanding Investigator AwardR35NS122140 · NINDS · UNIVERSITY OF CALIFORNIA-IRVINE · PI ALBERT R LA SPADA · 2021 to 2026
$7.2MDynamic regulatory network models of human response to influenza virusU01AI150748 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI MARAZZI, IVAN, MIRALDI, EMILY · 2020 to 2024
$5.8MRegulation of inflammatory gene expression during SARS2 infectionR01AI168130 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI Ivan Marazzi · 2022 to 2026
$3.7MAltered inflammatory response associated with acquired DNMT3A mutationsR01HL153974 · NHLBI · UNIVERSITY OF CALIFORNIA-IRVINE · PI BYUN, MINJI · 2021 to 2025
$3.3MMechanisms of FUS Toxicity in Animal and Cellular Models of ALS/FTD.R01NS106236 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SHNEIDER, NEIL ALAN · 2019 to 2022
$2.6MA host-dependent mechanism controlling influenza virus infection by suppressing viral RNA synthesisR01AI143840 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MARAZZI, IVAN · 2019 to 2023
$2.1MInterdisciplinary Training in Systems and Developmental Biology and Birth DefectsT32HD075735 · NICHD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI JABS, ETHYLIN WANG · 2013 to 2022
$1.8MAn integrated therapeutic T cell receptor screening platform for adoptive cell therapy in cancerR33CA225539 · NCI · UNIVERSITY OF TEXAS AT AUSTIN · PI JIANG, NING JENNY · 2018 to 2022
$1.1M